Initiative / ART-CC

Antiretroviral Therapy Cohort Collaboration

Antiretroviral Therapy Cohort Collaboration

Studies 0
Estimate prognosis of HIV-1 positive, treatment naïve patients initiating highly active antiretroviral therapy (ART)
Visit ART-CC

Members

Investigators Contacts
  • Dr. Lei Zhang
    University of Bristol
  • Dr. Adam Trickey
    University of Bristol
  • Dr. Suzanne Ingle
    University of Bristol
  • Dr. Prof. Jonathan Sterne
    University of Bristol

General Information

Year created
2000
Types of cohorts
  • Patient/disease cohort
Countries
  • Austria
  • Canada
  • Greece
  • France
  • Netherlands
  • Germany
  • Spain
  • Denmark
  • Italy
  • Switzerland
  • United States of America
Region
Western Europe and North America
Setting
International
Funding
Currently supported by the US National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Criteria of cohort's to be included
Prospective cohort studies are eligible to participate if they have enrolled at least 100 HIV-1–positive patients aged 16 years or older who have not previously received antiretroviral treatment, who began ART with a combination of at least three antiretroviral drugs after 1996, and who have been followed for a median of at least 1 year after the initiation of ART.
Health topic
  • Ageing
  • Cancer
  • Respiratory diseases
  • Communicable diseases
  • Biomedicine
  • Other : HIV and Addictive behaviours

Participants

Number of participants

Total
200,000

Age range of the samples

Minimum age
16
Maximum age
91

Methodology for harmonization and integration

Strategy of harmonization
Ex-post
Data processing methods
  • NA
  • Type of infrastructure
    Data are centrally located
    Integrative data analysis
    • Pooled analyses
    Software
  • Stata
  • SAS
  • NA
  • Supplementary information
    https://academic.oup.com/ije/article/43/3/691/757695 May, Margaret T., et al. "Cohort profile: antiretroviral therapy cohort collaboration (ART-CC)." International journal of epidemiology 43.3 (2014): 691-702.

    Number of cohorts

    Total
    20
    With harmonized data
    20
    Will more cohorts be harmonized?
    Number of harmonized variables (max.)
    20

    Access

    Availability of metadata
    Under request
    Availability of individual data